Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma

Nornazirah Azizan and Firdaus Hayati and Nur Maya Sabrina Tizen and Wirda Indah Farouk and Noraidah Masir (2018) Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma. Investigative and Clinical Urology, 59. pp. 232-237. ISSN 2466-0493 (P-ISSN) , 2466-054X (E-ISSN)

[img] Text
Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma FULL TEXT.pdf
Restricted to Registered users only

Download (522kB) | Request a copy
[img] Text
Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma ABSTRACT.pdf

Download (64kB)

Abstract

Purpose: To evaluate the expression of estrogen receptor (ER)-beta and Ki67 in prostate cancer and study their relationship. Materials and Methods: We analyzed 101 cases of prostate adenocarcinoma diagnosed from January 2011 to June 2015 in 100 patients. Immunohistochemical staining of ER-beta and Ki67 was analyzed according to Gleason score categorized into prognostic groups of 1 to 5. Double-immunofluorescent staining of ER-beta and Ki67 was performed in a total of 20 cases to study the co-expression and the relationship between these markers within the same tumor. Results: A total of 53 of 101 cases (52.5%) were positive for ER-beta expression. There was a positive correlation whereby a high percentage of ER-beta expression was seen in the higher prognostic groups (groups 4 and 5; p=0.007). High Ki67 expression was observed in the higher prognostic group, whereas low Ki67 or negative expression was found in the lower prognostic group (p<0.001). The majority of cases evaluated with double-immunofluorescent staining (14/20) showed co-expression of ER-beta and Ki67 at the individual cell level. Conclusions: ER-beta and Ki67 are independent tumor markers in high prognostic groups. Hence, co-expression of ER-beta and Ki67 indicates a more aggressive tumor with a poorer prognosis.

Item Type: Article
Uncontrolled Keywords: Estrogen receptor beta , Ki-67 antigen , Neoplasm grading , Prostate neoplasms
Subjects: R Medicine > RC Internal medicine > RC31-1245 Internal medicine > RC581-951 Specialties of internal medicine > RC870-923 Diseases of the genitourinary system. Urology
Divisions: FACULTY > Faculty of Medicine and Health Sciences
Depositing User: SAFRUDIN BIN DARUN -
Date Deposited: 22 Oct 2021 11:29
Last Modified: 22 Oct 2021 11:29
URI: http://eprints.ums.edu.my/id/eprint/30583

Actions (login required)

View Item View Item